| # | Drug | Count |
|---|---|---|
| 0 | ERGOCALCIFEROL | 15 |
| 1 | GABAPENTIN | 14 |
| 2 | ACETAMINOPHEN | 13 |
| 3 | ASPIRIN | 13 |
| 4 | ASPIRIN 325 MG | 13 |
| 5 | ASPIRIN 81 MG | 13 |
| 6 | DICLOFENAC SODIUM | 10 |
| 7 | METOPROLOL | 10 |
| 8 | METOPROLOL TARTRATE | 10 |
| 9 | HYDROCHLOROTHIAZIDE | 9 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RUTIN | 1 | 0.0112 |
| 1 | SODIUM ACETATE | 3 | 0.0105 |
| 2 | L-GLUTAMINE | 1 | 0.0028 |
| 3 | PSYLLIUM HUSK | 2 | 0.0015 |
| 4 | CAPLACIZUMAB | 2 | 0.0011 |
| 5 | ACYCLOVIR SODIUM | 1 | 0.0008 |
| 6 | QUERCETIN | 1 | 0.0008 |
| 7 | POLYETHYLENE GLYCOL 3350, SODIUM SULFATE ANHYDROUS, SODIUM BICARBONATE, SODIUM CHLORIDE, POTASSIUM CHLORIDE | 1 | 0.0008 |
| 8 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 3 | 0.0007 |
| 9 | BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY | 4 | 0.0006 |
| # | Drug class | Count |
|---|---|---|
| 0 | Nonsteroidal Anti-inflammatory Drug [EPC] | 26 |
| 1 | Corticosteroid [EPC] | 17 |
| 2 | Benzodiazepine [EPC] | 16 |
| 3 | Osmotic Laxative [EPC] | 15 |
| 4 | Provitamin D2 Compound [EPC] | 15 |
| 5 | Platelet Aggregation Inhibitor [EPC] | 13 |
| 6 | Vitamin C [EPC] | 13 |
| 7 | Atypical Antipsychotic [EPC] | 11 |
| 8 | Thiazide Diuretic [EPC] | 11 |
| 9 | beta-Adrenergic Blocker [EPC] | 11 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD38-directed Cytolytic Antibody [EPC] | 4 | 0.0007 |
| 1 | Provitamin D2 Compound [EPC] | 15 | 0.0005 |
| 2 | Guanylate Cyclase-C Agonist [EPC] | 1 | 0.0005 |
| 3 | CCR5 Co-receptor Antagonist [EPC] | 1 | 0.0004 |
| 4 | Cytomegalovirus pUL97 Kinase Inhibitor [EPC] | 1 | 0.0004 |
| 5 | Cytomegalovirus DNA Terminase Complex Inhibitor [EPC] | 1 | 0.0003 |
| 6 | Cannabinoid [EPC] | 2 | 0.0002 |
| 7 | Survival of Motor Neuron 2 Splicing Modifier [EPC] | 1 | 0.0002 |
| 8 | Substance P/Neurokinin-1 Receptor Antagonist [EPC] | 2 | 0.0002 |
| 9 | Selective T Cell Costimulation Blocker [EPC] | 1 | 0.0002 |